Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Lundbeck Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (28)
Australian Public Assessment Report (AusPAR) (6)
Cancellation by sponsor (5)
Section 14, TGO91 consent (3)
Prescription medicine registration (2)

Date

2024 (1)
2022 (1)
2021 (3)
2020 (3)
2019 (4)
2018 (3)
2017 (7)
2016 (1)
2014 (8)
2012 (1)
2011 (1)
2009 (1)
2003 (2)
1997 (1)
1994 (3)
1993 (4)

Results for "[search-keyword]"

Search

Sponsor content

44 result(s) found, displaying 11 to 20

EBIXA memantine hydrochloride 10mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 November 2019

Cancellation by sponsor

Requested by Lundbeck Australia Pty Ltd
SELINCRO nalmefene (as hydrochloride dihydrate) 18 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 November 2019

Cancellation by sponsor

Requested by Lundbeck Australia Pty Ltd
REXULTI brexpiprazole 1 mg film coated tablet blister pack (273220)

19 May 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for REXULTI brexpiprazole 1 mg film coated tablet blister pack.
REXULTI brexpiprazole 3 mg film coated tablet blister pack (273221)

19 May 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for REXULTI brexpiprazole 3 mg film coated tablet blister pack.
REXULTI brexpiprazole 0.5 mg film coated tablet blister pack (273222)

19 May 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for REXULTI brexpiprazole 0.5 mg film coated tablet blister pack.
REXULTI brexpiprazole 2 mg film coated tablet blister pack (273223)

19 May 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for REXULTI brexpiprazole 2 mg film coated tablet blister pack.
REXULTI brexpiprazole 4 mg film coated tablet blister pack (273224)

19 May 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for REXULTI brexpiprazole 4 mg film coated tablet blister pack.
REXULTI brexpiprazole 0.25 mg film coated tablet blister pack (273225)

19 May 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for REXULTI brexpiprazole 0.25 mg film coated tablet blister pack.
LUNDBECK AUSTRALIA PTY LTD - Medicine administration kit, oral Cancelled under Section 41GL(d) of the Act

5 June 2019

Cancellation by sponsor

Requested by Lundbeck Australia Pty Ltd
ABBAPRAM citalopram (as hydrobromide) 20mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

5 June 2019

Cancellation by sponsor

Requested by Lundbeck Australia Pty Ltd

Pages

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.